Picture of Epirus Biopharmaceuticals logo

EPRSQ — Epirus Biopharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Epirus Biopharmaceuticals provided written notice to terminate purchase agreement

Jan 26 (Reuters) - EPIRUS Biopharmaceuticals Inc  EPRS.O : 
 * On January 23, co provided written notice to terminate certain purchase 
   agreement with Lincoln park capital fund, llc 
 * Epirus biopharmaceuticals-co will not incur any early termination penalties 
   in connection with the termination of the purchase agreement 
 * Source text for Eikon (http://1.usa.gov/1LcGw2L) 
 * Further company coverage  EPRS.O   
 
  ((Bengaluru Newsroom; +1 646 223 8780))

Recent news on Epirus Biopharmaceuticals

See all news